BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2582970)

  • 1. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
    Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
    Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells.
    Demarcq C; Bastian G; Remvikos Y
    Cytometry; 1992; 13(4):416-22. PubMed ID: 1526199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-phase arrest of nutrient deprived lung cancer cells.
    Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
    Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
    Perras JP; Ramos R; Sevin BU
    Cytometry; 1993; 14(4):441-8. PubMed ID: 8513698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
    Begg AC; Hofland I
    Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
    Shimizu T
    Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etoposide effect on cell cycle kinetics of a human lung cancer cell line].
    Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Inoue S; Kawakami Y; Mizuno S
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1237-43. PubMed ID: 6732252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
    Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
    Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokinetic effects of anticancer drugs on a human lung cancer cell line using monoclonal antibody against bromodeoxyuridine].
    Miyamoto H; Isobe H; Ito M; Mizuno S; Kawakami Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3541-5. PubMed ID: 3789763
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents].
    Ito M
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):718-36. PubMed ID: 2430876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine.
    White RA; Terry NH
    Cytometry; 1992; 13(5):490-5. PubMed ID: 1633728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer chemo-endocrine therapy and its cell biological basis].
    Nishiya I
    Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.